Influenza Vaccination Linked to Reduced Risk of Major Cardiovascular Events
A recent study has unveiled a potentially significant correlation between influenza vaccination and a decreased risk of major cardiovascular events. The research aimed to assess the impact of influenza vaccination on cardiovascular health, exploring its potential as a preventive strategy against severe cardiovascular incidents. This study was published in Nature journal by Omidi F. and colleagues.
The study conducted an extensive review of medical literature, analyzing data from PubMed/MEDLINE, EMBASE, and the Cochrane CENTRAL databases up to August 1, 2023. A meta-analysis was employed, encompassing a comprehensive evaluation of specific outcomes, including myocardial infarction (MI), cardiovascular death, and stroke.
Involving a total of 9059 patients, the study revealed compelling evidence supporting the benefits of influenza vaccination. Among patients who received the influenza vaccine, a noteworthy reduction in major cardiovascular events was observed. Specifically, 517 cases were reported in the vaccinated group compared to 621 cases in the placebo group, resulting in a Relative Risk (RR) of 0.70 (95% CI 0.55–0.91).
Further stratified analysis unearthed significant insights. Patients who received the influenza vaccine demonstrated a decreased risk of myocardial infarction (RR 0.74; 95% CI 0.56–0.97) and a notable reduction in cardiovascular death events (RR 0.67; 95% CI 0.45–0.98).
The study underscores a compelling association between influenza vaccination and a reduced risk of major cardiovascular events, particularly myocardial infarction and cardiovascular death. These findings potentially position influenza vaccination as an adjunctive strategy in cardiovascular disease prevention.
While the study offers promising insights, further research is warranted to delve into the underlying mechanisms driving this observed beneficial effect. Continued exploration and understanding of the intricate relationship between influenza vaccination and cardiovascular health could potentially revolutionize preventive strategies against cardiovascular diseases.
Reference:
Omidi, F., Zangiabadian, M., Shahidi Bonjar, A. H., Nasiri, M. J., & Sarmastzadeh, T. Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies. Scientific Reports,2023;13(1):1–7. https://doi.org/10.1038/s41598-023-47690-9
